J
John A. Baron
Researcher at University of North Carolina at Chapel Hill
Publications - 621
Citations - 65704
John A. Baron is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 128, co-authored 609 publications receiving 61182 citations. Previous affiliations of John A. Baron include Dartmouth College & Boston University.
Papers
More filters
Journal ArticleDOI
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
Robert S. Bresalier,Robert S. Sandler,Hui Quan,James A. Bolognese,Bettina Oxenius,Kevin J. Horgan,Christopher Lines,Robert H. Riddell,Dion Morton,Angel Lanas,Marvin A. Konstam,John A. Baron +11 more
TL;DR: Among patients with a history of colorectal adenomas, the use of rofecoxib was associated with an increased cardiovascular risk, and cardiovascular mortality was similar in the two groups.
Tobacco smoke and involuntary smoking
Michael C. R. Alavanja,John A. Baron,Ross C. Brownson,Patricia A. Buffler,David M. DeMarini,Mirjana V. Djordjevic,Richard Doll,Elizabeth T. H. Fontham,Yu-Tang Gao,Nigel Gray,Prakash C. Gupta,A. K. Hackshaw,Stephen S. Hecht,Kirsti Husgafvel-Pursiainen,Elena Matos,Richard Peto,David H. Phillips,Jonathan M. Samet,Gary D. Stoner,Michael J. Thun,Jean Trédaniel,Paolo Vineis,H.-Erich Wichmann,Anna H. Wu,David Zaridze +24 more
Journal ArticleDOI
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials
Colin Baigent,Neeraj Bhala,Jonathan Emberson,A Merhi,S. Abramson,Nadir Arber,John A. Baron,Claire Bombardier,Christopher P. Cannon,Michael E. Farkouh,Garret A. FitzGerald,Paul E. Goss,Heather Halls,Ernest T. Hawk,Christopher J. Hawkey,C H Hennekens,Marc C. Hochberg,Lisa Holland,Patricia M. Kearney,Loren Laine,Angel Lanas,Peter Lance,Andreas Laupacis,Jim C. Oates,Carlo Patrono,Thomas J. Schnitzer,Scott D. Solomon,Peter Tugwell,Kate Wilson,Janet Wittes,O. Adelowo,P. Aisen,Abdulaziz A Al-Quorain,Roy D. Altman,George L. Bakris,H. Baumgartner,C. Bresee,M. Carducci,D. M. Chang,C. T. Chou,D. Clegg,M. Cudkowicz,L. Doody,Y. El Miedany,Claire Falandry,J. Farley,Leslie G. Ford,M. Garcia-Losa,M. Gonzalez-Ortiz,M. Haghighi,M. Hala,T. Iwama,Zrinka Jajić,David J. Kerr,H. S. Kim,C.-H. Köhne,B. K. Koo,Barbara K. Martin,Curtis L. Meinert,N. Muller,G. Myklebust,D. Neustadt,R. Omdal,S. Ozgocmen,A. Papas,Paola Patrignani,F. Pelliccia,V. Roy,I. Schlegelmilch,Asad Umar,O. Wahlstrom,F. Wollheim,S. Yocum,X. Y. Zhang,E. Hall,Patricia McGettigan,R Midgley,R. A. Moore,R. Philipson,Sean P. Curtis,Alise S. Reicin,John H. Bond,Ami R. Moore,M. Essex,J. Fabule,B. Morrison,Leslie Tive,Kelly Davies,F. Yau +88 more
TL;DR: Although NSAIDs increase vascular and gastrointestinal risks, the size of these risks can be predicted, which could help guide clinical decision making.
Journal ArticleDOI
Prognosis of cancers associated with venous thromboembolism.
TL;DR: In this article, the authors linked the Danish National Registry of Patients, the Danish Cancer Registry, and the Danish Mortality Files to obtain data on the survival of patients who received a diagnosis of cancer at the same time as or after an episode of venous thromboembolism.
Journal ArticleDOI
A randomized trial of aspirin to prevent colorectal adenomas
John A. Baron,Bernard F. Cole,Robert S. Sandler,Robert W. Haile,Dennis J. Ahnen,Dennis J. Ahnen,Robert S. Bresalier,Gail McKeown-Eyssen,Robert W. Summers,Richard I. Rothstein,Carol A. Burke,Dale C. Snover,Timothy R. Church,John I. Allen,Michael L. Beach,Gerald J. Beck,John H. Bond,John H. Bond,Tim Byers,E. Robert Greenberg,Jack S. Mandel,Norman E. Marcon,Leila A. Mott,Loretta H. Pearson,Fred Saibil,Rosalind U. van Stolk +25 more
TL;DR: Low-dose aspirin has a moderate chemopreventive effect on adenomas in the large bowel, using generalized linear models to compute risk ratios and 95 percent confidence intervals.